Recent posts

TypePostAuthorRepliesLast updated
Blog entryWTO: Spotlight on the United States at the Trade Policy Review (December 2012) thiru011 weeks 2 days ago
Blog entryRejected letter to Foreign Affairs, responding to "Healthy Governance" article about WHO James Love111 weeks 5 days ago
Blog entryEB140: WHO adopts decision on terms of reference for overall programme review of the GSPOA (31 Jan 2017) thiru012 weeks 3 days ago
Blog entryEB140 heats up during discussions of proposed changes to resolution on TOR of Overall Programme Review of GSPOA thiru012 weeks 6 days ago
Blog entryChilean Cámara de Diputados votes overwhelmingly to advance compulsory licensing of drug patents. Andrew Goldman013 weeks 1 day ago
PageZika James Love013 weeks 3 days ago
PageAntimicrobial resistance (AMR) James Love013 weeks 3 days ago
Blog entryKEI proposal for Antibiotics Innovation Funding Mechanism (AIFM), shortlisted for demonstration project by WHO's EURO region James Love013 weeks 4 days ago
Blog entryEB140: Statement of India on the Report of the United Nations High-Level Panel on Access to Medicines thiru013 weeks 4 days ago
PageDr. Diane Singhroy, Scientific and Technical Advisor Claire Cassedy014 weeks 2 days ago
Blog entryGroups Object to Army Proposal to Give Sanofi a Monopoly on Patents for Taxpayer-Funded Zika Vaccine James Love014 weeks 2 days ago
Blog entryKlobuchar Drug Importation Amendment Sees Votes Crossing the Aisle Zack Struver015 weeks 1 day ago
Blog entryKEI initial opposition to U.S. Army grant of exclusive license to Sanofi on patents for Zika virus vaccine KEI Staff015 weeks 1 day ago
PageBackground FAQ on Glivec (imatinib) compulsory license in Colombia Zack Struver018 weeks 2 days ago
Blog entryColombia finalizes 44% price reduction of leukemia drug Glivec Andrew Goldman018 weeks 2 days ago
Blog entrySCP25: Closing Statement of the Republic of South Africa thiru018 weeks 2 days ago
Blog entryFront page New York Times story explores Kite Pharma's profitable relationship with NIH regarding expensive cancer drug Zack Struver018 weeks 3 days ago
PageNIH licenses (patents, data) and comments on proposed exclusive licenses James Love018 weeks 3 days ago
Blog entry2016: KEI Comments on NIH Proposed Exclusive License to Kite Pharma for Cancer Treatment Claire Cassedy018 weeks 3 days ago
Blog entryKEI Dec 9, 2016 comments to NIST on Bayh-Dole Act Regulations James Love018 weeks 6 days ago
Blog entrySCP25: South Africa’s Experience Related to the Topic of Access to Medicines thiru019 weeks 2 days ago
Blog entryPCB39: Address of Justice Michael Kirby - HIV/AIDS & Solidarity - 30 Years On thiru019 weeks 2 days ago
Blog entrySCP25: Statement of Asia Pacific Group on Patents and Health thiru019 weeks 3 days ago
Blog entrySCP25: Statement of the Republic of South Africa on Patents and Health thiru019 weeks 3 days ago
Blog entryUSPTO meeting on "Developing the Digital Marketplace for Copyrighted Works" Dec. 9, 2016 Andrew Goldman019 weeks 3 days ago